Melinda Moree, Ph.D.
Dr. Moree is Director of the Malaria Vaccine Initiative, which is at the forefront of the global drive to develop safe, effective, and affordable malaria vaccines. MVI works with government, industry, and academic partners on five continents to push forward promising malaria vaccine candidates. As director, Dr. Moree seeks to ensure the highest quality in all program activities, a continued commitment to existing relationships, and the forging of new partnerships.
Prior to assuming leadership of MVI, Dr. Moree was Senior Business Development Officer for MVI. As one of the first MVI team members, Dr. Moree has worked to identify the commercial barriers to malaria vaccine development, addressing such issues as intellectual property rights, guaranteed purchase of vaccine, market assessment and demand, and financial incentives for research and development. Prior to joining PATH in 1999, Dr. Moree was Manager of Advanced Research at EKOS Corporation and worked in technology transfer at the University of Washington. Before that, she gained public-private development experience while serving as an American Association for the Advancement of Science (AAAS) Science and Diplomacy fellow at USAID. Dr. Moree received her Ph.D. in medical microbiology from the University of Maryland at Baltimore.
Adrian Hill, M.B., B.Chir., D.Phil.
Professor Adrian V. S. Hill is a Wellcome Trust Principal Research Fellow at the Institute of Molecular Medicine and Wellcome Trust Centre for Human Genetics at the University of Oxford. He qualified from Oxford Clinical School in 1982 and undertook a D.Phil. in human population genetics at the MRC Molecular Haematology Unit. Following further clinical training, he returned to Oxford in 1988 to the newly created Institute of Molecular Medicine. With collaborators in Africa and Asia, he has contributed to our understanding of the genetics of susceptibility to several infectious diseases, especially malaria and tuberculosis, and to vaccine design and development. His group has recently undertaken clinical trials of new T cell-inducing malaria vaccines designed and developed in the Oxford department. In 1999 he was elected a Fellow of the Royal College of Physicians and of the U.K. Academy of Medical Sciences.
Dr. Folasade Olodude, MB, ChB
Dr. Folasade Olodude works as a Research Pediatrician at the Medical Research Council Laboratories in The Gambia. She is a Fellow of the West African College of Physicians. She previously worked as a pediatrician in the Citizen Medical Centre in Lagos, Nigeria; as Senior Registrar in Paediatric Cardiology at the Lagos University Teaching Hospital in Ibadan, Nigeria; and as Senior Registrar for Emergency pediatrics at the Lagos University Teaching Hospital. Dr. Olodude has also worked in neonatal intensive care and community pediatrics. She has more than ten years of experience working as a hospital pediatrician in Sub-Saharan Africa, where malaria is endemic.
Dr. Olodude was the Co-Investigator of two sequential phase 1 trials of the RTS,S/AS02A GlaxoSmithKline Biologicals candidate malaria vaccine in Gambian children. The first trial was in children aged six to 11 years; the second in children aged one to five years. She is currently working on studies of the age-specific incidence rates of malaria in children under five years of age, and their antibody responses to malaria. Dr. Olodude completed a postgraduate six-year fellowship under the West African Postgraduate College of Physicians. She earned her medical degree at Obafemi Awolowo University, Ile-Ife Nigeria.
Filip Dubovsky, M.D., M.P.H., F.A.A.P
Dr. Filip Dubovsky is Scientific Director of the Malaria Vaccine Initiatve. A pediatrician, infectious disease specialist, and vaccinologist by training, Dr. Dubovsky directs portfolio management, technology assessment, and project development for MVI. He also provides scientific oversight to all MVI product development teams.
Dr. Dubovsky received his Doctor of Medicine from the University of Alabama-Birmingham, and completed his pediatric residency and chief residency at Stanford University. At the Center for Vaccine Development, he specialized in molecular biology, studying molecular pathogenesis of diseases that primarily affect developing countries, while being certified in Pediatric Infectious Diseases at the University of Maryland at Baltimore. He received his Master of Public Health degree and certification in Vaccine Science and Policy from the Johns Hopkins University School of Public Health. Dr. Dubovsky has served on an NIH study section, participated as a WHO expert on ethics of pediatric clinical trials, and served as technical consultant to US and European biotechnology companies. Dr. Dubovsky is currently a member of the WHO Advisory Committee on Malaria Vaccines.
Pedro Alonso, M.D., M.S., Ph.D.
Dr. Pedro Alonso is Head of the Center for International Health at the Hospital Clinic of the University of Barcelona and Director of Centro de Investigaçao em Saude Manhiça, Mozambique. He serves as Principal Investigator of the RTS,S/AS02A malaria vaccine clinical trial in Mozambique. Dr. Alonso was previously a medical epidemiologist for both the Spanish Council for Scientific Research at the Institute of Parasitology “López Neyra,” and for the U.K. Medical Research Council. After receiving his degree in medicine from the Universidad Autónoma de Madrid in 1984, he went on to earn his M.S. in Epidemiology and Control of Communicable Diseases from the London School of Hygiene and Tropical Medicine. More recently, he completed his Ph.D. from the University of Barcelona. Dr. Alonso’s research relating to malaria has been published in the medical journals Lancet, the Journal of Infectious Diseases, and Tropical Medicine and International Health.
Kojo Koram, MB, ChB, Ph.D.
Dr. Koram is the Head of the Epidemiology Unit at the Noguchi Memorial
Institute for Medical Research, University of Ghana, in Accra, where he
is also a Senior Research Fellow and Lecturer in Epidemiology. In addition,
he serves on the Scientific Advisory Panel of the African Malaria Network
Trust (AMANET), and on the Editorial Board of the Ghana Medical Journal.
Previously, Dr. Koram was a Scientific Officer in Epidemiology at the MRC
Laboratories in The Gambia. He served as a Medical Officer and District
Medical Officer in Bakwa, Ghana, and as House Officer at the Korle-Bu Teaching
Hospital in Accra. Dr. Koram was also a Member of the Coordinating Committee
of the African Malaria Vaccine Testing Network (AMVTN) from its inception
till its evolution into AMANET. He helped to conduct several of AMVTN's
courses on vaccine trials and health research ethics. Dr. Koram earned his
medical degree at the University of Ghana Medical School in Accra, his Masters
of Public Health and Tropical Medicine at Tulane University, in New Orleans,
Louisiana, and his Ph.D. in Epidemiology at the London School of Hygiene
and Tropical Medicine in London.
This page displays best in a browser that supports current web standards, but all content is accessible via any web device.
